Ananda Ghosh Analyst PerformanceVice President । Research Analyst | Biotech Equity Research at HC WainwrightAnanda Ghosh is a stock analyst at HC Wainwright in the medical sector, covering 10 publicly traded companies. Over the past year, Ananda Ghosh has issued 28 stock ratings, including buy and hold recommendations. While full access to Ananda Ghosh's proprietary MarketBeat Analyst Ranking is reserved for MarketBeat All Access subscribers, the rating is updated daily to reflect the most recent analyst activity. This profile highlights Ananda Ghosh's coverage history, rating activity, and performance tendencies — helping individual investors make more informed trading decisions. Analyst Rankings, Coverage, and Performance StatisticsAnalyst RankingSubscribe to MarketBeat All Access for the analyst's recommendation accuracy rating MarketBeatAverage Return00.00% 12-Month ROISuccess Rate00.00% Profitable RatingsTotal Ratings28 Last 0 YearsBuy Recommendations92.86% 26 Buy RatingsCompanies Covered10 Unique Companies Ratings Distribution28RatingsDistribution of strong buy, buy, hold, and sell ratings by Ananda Ghosh.RatingPercentageCount Strong Buy0.0%0 ratings Buy92.9%26 ratings Hold7.1%2 ratings Sell0.0%0 ratingsOut of 28 total stock ratings issued by Ananda Ghosh at HC Wainwright, the majority (92.9%) have been Buy recommendations, followed by 7.1% Hold.Best & Worst CallsThis analyst does not have any ratings with enough history to determine best and worst calls.Exchange CoverageExchangePercentageCountNASDAQ100.0% of companies on NASDAQ10 companiesAnanda Ghosh, an analyst at HC Wainwright, currently covers 10 companies listed on , with the majority traded on NASDAQ.Coverage FocusSector IconSectorPercentageMedical10 companies100.0%Ananda Ghosh of HC Wainwright specializes in stock coverage within the Medical sector.Coverage IndustriesIndustryPercentageMED - BIOMED/GENE9 companies90.0%MED - DRUGS1 company10.0% Ananda Ghosh's Ratings History at HC Wainwright Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years 4 Years 5 Years All Time Timeframe Start Date End Date All Ratings Strong Buy Buy Hold Sell Rating Recommendation ROI is the percentage between the price on the Report Date to the price 12 months after the report date.Available with a MarketBeat All Access Subscription12-Month ROIUpgrade to All Access to use the All ROI Filter Export CompanyReport DateActionReport Date Price12-MonthPrice TargetRating12-MonthPrice & ROIDetailsRNAAvidity Biosciences5/1/2026Reiterated Rating$12.77Neutral$0.0000.00% ROIMAZEMaze Therapeutics3/25/2026Boost Price Target$30.34$110.00Buy$0.0000.00% ROIGPCRStructure Therapeutics3/16/2026Lower Price Target$58.26$100.00Buy$0.0000.00% ROIDYNDyne Therapeutics3/3/2026Lower Price Target$16.15$50.00Buy$0.0000.00% ROIGPCRStructure Therapeutics3/2/2026Boost Price Target$62.98$114.00Buy$0.0000.00% ROIACADACADIA Pharmaceuticals2/3/2026Reiterated Rating$26.13$37.00Buy$0.0000.00% ROIIVAInventiva1/28/2026Set Price Target$6.90$24.00Buy$0.0000.00% ROIMAZEMaze Therapeutics1/28/2026Reiterated Rating$44.36Buy$0.0000.00% ROIGPCRStructure Therapeutics12/19/2025Boost Price Target$62.45$90.00Buy$0.0000.00% ROIACADACADIA Pharmaceuticals12/15/2025Boost Price Target$27.24$37.00Buy$0.0000.00% ROI Get the Latest News and Ratings for Your StocksEnter your email address below to receive the latest headlines and analysts' recommendations for your stocks with our free daily email newsletter. STOKStoke Therapeutics12/15/2025Boost Price Target$32.39$50.00Buy$0.0000.00% ROIDYNDyne Therapeutics12/8/2025Boost Price Target$23.33$60.00Buy$0.0000.00% ROIMAZEMaze Therapeutics12/3/2025Boost Price Target$38.28$60.00Buy$0.0000.00% ROIGPCRStructure Therapeutics11/28/2025Reiterated Rating$34.22$60.00Buy$0.0000.00% ROIPEPGPepGen11/13/2025Boost Price Target$4.94$20.00Buy$0.0000.00% ROIDYNDyne Therapeutics11/6/2025Boost Price Target$18.00$46.00Buy$0.0000.00% ROIRNAAvidity Biosciences10/27/2025Downgrade$49.15$72.00Neutral$0.0000.00% ROIPEPGPepGen10/27/2025Boost Price Target$5.43$18.00Buy$0.0000.00% ROIIVAInventiva10/9/2025Boost Price Target$5.36$24.00Buy$0.0000.00% ROISKYESkye Bioscience9/30/2025Initiated Coverage$3.88$20.00Buy$0.0000.00% ROIPEPGPepGen9/25/2025Boost Price Target$2.66$12.00Buy$0.0000.00% ROIMAZEMaze Therapeutics9/18/2025Reiterated Rating$23.50$50.00Buy$0.0000.00% ROIRNAAvidity Biosciences9/12/2025Boost Price Target$41.04$87.00Buy$0.0000.00% ROIMAZEMaze Therapeutics9/12/2025Boost Price Target$24.80$50.00Buy$0.0000.00% ROIIVAInventiva9/3/2025Initiated Coverage$5.26$20.00Buy$0.0000.00% ROIANNXAnnexon8/15/2025Reiterated Rating$2.38$14.00Buy$0.0000.00% ROIGPCRStructure Therapeutics8/7/2025Lower Price Target$16.45$60.00Buy$0.0000.00% ROIMAZEMaze Therapeutics7/23/2025Initiated Coverage$16.94$34.00Buy$0.0000.00% ROI Stock Forecasts and Research Tools Today's Analyst Ratings U.S. Ratings U.K. Ratings Canadian Ratings All Upgrades All Downgrades All Initiations All Price Target Changes Top-Rated Stocks Top Rated Stocks Top-Rated Dividend Stocks Top-Rated Small-Cap Stocks Top-Rated Tech Stocks Most-Upgraded Stocks Most-Downgraded Stocks Lowest-Rated Stocks More Ratings Tools Stock Ratings by Issuer Top-Rated Analysts Top-Rated Brokerages Stock Ratings Screener Free Ratings Newsletter Price Forecasts for Popular Stocks Alphabet (Google) Stock ForecastAmazon Stock ForecastApple Stock ForecastMeta (Facebook) Stock ForecastMicrosoft Stock ForecastNetflix Stock ForecastNvidia Stock ForecastTesla Stock Forecast Top Stock Recommendations by BrokerageWall Street ZenJefferies Financial GroupWeiss RatingsUBS GroupCitigroupBarclaysWells Fargo & CompanyMorgan StanleyRoyal Bank Of CanadaJPMorgan Chase & Co.The Goldman Sachs GroupTD CowenTruist FinancialPiper SandlerStifel Nicolaus Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
